Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24455 | 22876924 | Curr Med Chem | Adiponectin: key player in the adipose tissue-liver crosstalk. | 2012 | Details |
| A24457 | 22876042 | World J Gastroenterol | Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude. | 2012 | Details |
| A24458 | 22876038 | World J Gastroenterol | Moro orange juice prevents fatty liver in mice. | 2012 | Details |
| A24459 | 22876027 | World J Gastroenterol | Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24460 | 22876026 | World J Gastroenterol | Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome. | 2012 | Details |
| A24461 | 22875138 | Pediatr Cardiol | The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. | 2012 | Details |
| A24462 | 22872676 | FASEB J | Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism. | 2012 | Details |
| A24463 | 22871994 | Clin Pharmacol Ther | Nrf2: a potential target for new therapeutics in liver disease. | 2012 | Details |
| A24464 | 22871499 | J Hepatol | Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. | 2012 | Details |
| A24465 | 22871498 | J Hepatol | Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. | 2012 | Details |
| A24466 | 22869157 | J Gastroenterol | The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. | 2012 | Details |
| A24467 | 22868011 | J Coll Physicians Surg Pak | Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis? | 2012 | Details |
| A24468 | 22864747 | Arch Pharm Res | Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats. | 2012 | Details |
| A24469 | 22864348 | Yakugaku Zasshi | [Retinoids as promising treatment for non-alcoholic fatty liver disease]. | 2012 | Details |
| A24470 | 22864259 | Eur J Gastroenterol Hepatol | Ursodeoxycholic acid for nonalcoholic steatohepatitis. | 2012 | Details |
| A24472 | 22863080 | Liver Int | α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. | 2012 | Details |
| A24473 | 22858825 | Mol Med Rep | Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c. | 2012 | Details |
| A24475 | 22857151 | Pharm Biol | Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. | 2012 | Details |
| A24476 | 22855698 | World J Hepatol | Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China. | 2012 | Details |
| A24477 | 22855696 | World J Hepatol | Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24478 | 22855443 | Dongwuxue Yanjiu | [Effects of resistin on hepatic fibrosis: possible mechanisms in non-alcoholic fatty liver disease in in vitro and in vivo]. | 2012 | Details |
| A24479 | 22854109 | Metabolism | High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. | 2012 | Details |
| A24480 | 24660114 | Med Chem (Los Angeles) | Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis. | 2012 | Details |
| A24481 | 22851489 | J Clin Endocrinol Metab | Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. | 2012 | Details |
| A24482 | 22850810 | Wien Klin Wochenschr | The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24483 | 22849970 | Br J Nutr | Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. | 2012 | Details |
| A24484 | 22848440 | PLoS One | Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24485 | 22847887 | Liver Transpl | Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis. | 2012 | Details |
| A24486 | 22846856 | Semin Oncol | Causes of and prevention strategies for hepatocellular carcinoma. | 2012 | Details |
| A24487 | 22846353 | Clin Calcium | [Magnesium and liver]. | 2012 | Details |
| A24488 | 22846254 | Digestion | Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. | 2012 | Details |
| A24489 | 22846210 | Dis Markers | Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis. | 2012 | Details |
| A24490 | 22844567 | Gut Liver | Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men. | 2012 | Details |
| A24491 | 22843768 | Radiology | Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. | 2012 | Details |
| A24492 | 22843123 | Endocrine | Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. | 2012 | Details |
| A24493 | 22841818 | Am J Pathol | Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. | 2012 | Details |
| A24494 | 22841522 | Metabolism | Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24496 | 22840293 | Gastrointest Endosc | Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. | 2012 | Details |
| A24497 | 22837800 | Int J Clin Exp Med | Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding. | 2012 | Details |
| A24498 | 22837189 | J Clin Endocrinol Metab | Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. | 2012 | Details |
| A24499 | 22831974 | BMB Rep | Central energy metabolism remains robust in acute steatotic hepatocytes challenged by a high free fatty acid load. | 2012 | Details |
| A24500 | 22829522 | Diabetes Care | Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. | 2012 | Details |
| A24501 | 22829450 | Diabetes | Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. | 2012 | Details |
| A24502 | 22827449 | Clin Sci (Lond) | Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model. | 2013 | Details |
| A24503 | 22826613 | World J Gastroenterol | Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? | 2012 | Details |
| A24505 | 22824485 | Clin Liver Dis | Management of nonalcoholic steatohepatitis: an evidence-based approach. | 2012 | Details |
| A24506 | 22824484 | Clin Liver Dis | Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease. | 2012 | Details |
| A24507 | 22824483 | Clin Liver Dis | The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. | 2012 | Details |
| A24508 | 22824482 | Clin Liver Dis | Is nonalcoholic fatty liver disease in children the same disease as in adults? | 2012 | Details |
| A24509 | 22824481 | Clin Liver Dis | Can NASH be diagnosed, graded, and staged noninvasively? | 2012 | Details |
| A24510 | 22824480 | Clin Liver Dis | Mechanisms of disease progression in NASH: new paradigms. | 2012 | Details |
| A24511 | 22824479 | Clin Liver Dis | A myriad of pathways to NASH. | 2012 | Details |
| A24512 | 22824478 | Clin Liver Dis | Mechanisms of simple hepatic steatosis: not so simple after all. | 2012 | Details |
| A24513 | 22824477 | Clin Liver Dis | The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. | 2012 | Details |
| A24514 | 22824476 | Clin Liver Dis | The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine. | 2012 | Details |
| A24516 | 22821716 | Liver Transpl | Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation. | 2012 | Details |
| A24517 | 22820754 | Tohoku J Exp Med | The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease. | 2012 | Details |
| A24518 | 22820478 | J Hepatol | Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. | 2012 | Details |
| A24519 | 22819913 | Hepatogastroenterology | Roles of hepatic progenitor cells activation, ductular reaction proliferation and Notch signaling in morbid obesity. | 2012 | Details |
| A24520 | 22819708 | Eur J Pharmacol | Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells. | 2012 | Details |
| A24521 | 22817846 | Eur J Radiol | Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children. | 2012 | Details |
| A24522 | 22814750 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. | 2012 | Details |
| A24523 | 22811894 | Cholesterol | Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic Fatty liver disease in obese children? | 2012 | Details |
| A24524 | 22809960 | Dig Liver Dis | Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose tolerance. | 2012 | Details |
| A24525 | 22809102 | Annu Rev Nutr | Endoplasmic reticulum stress in nonalcoholic fatty liver disease. | 2012 | Details |
| A24526 | 22808787 | Eksp Klin Gastroenterol | [Nutrition mistakes in patients with nonalcoholic fatty liver disease and the ways of correction]. | 2012 | Details |
| A24527 | 22807031 | Diabetes | Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. | 2012 | Details |
| A24528 | 22806626 | Hepatology | Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia. | 2012 | Details |
| A24531 | 22796457 | Clin Gastroenterol Hepatol | Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. | 2012 | Details |
| A24532 | 22796347 | Nutr Metab Cardiovasc Dis | Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. | 2012 | Details |
| A24533 | 22796156 | J Hepatol | Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease. | 2012 | Details |
| A24534 | 22796155 | J Hepatol | Phenotyping the effect of diet on non-alcoholic fatty liver disease. | 2012 | Details |
| A24535 | 22795319 | Clin Res Hepatol Gastroenterol | Does fructose consumption contribute to non-alcoholic fatty liver disease? | 2012 | Details |
| A24536 | 22792295 | PLoS One | The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation. | 2012 | Details |
| A24537 | 22790906 | Dig Dis Sci | Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. | 2012 | Details |
| A24538 | 22790124 | Intern Med | Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study. | 2012 | Details |
| A24539 | 22789032 | Clin Endocrinol (Oxf) | Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. | 2013 | Details |
| A24540 | 22788090 | Rom J Intern Med | Non-alcoholic fatty liver disease and the statins treatment. | 2012 | Details |
| A24541 | 22780848 | Hepatol Res | Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study. | 2012 | Details |
| A24543 | 22770622 | Expert Opin Pharmacother | The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. | 2012 | Details |
| A24544 | 22770479 | BMC Gastroenterol | Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline. | 2012 | Details |
| A24545 | 22768838 | Cell Metab | Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. | 2012 | Details |
| A24546 | 22768831 | Cell Metab | Leptin in the liver: a toxic or beneficial mix? | 2012 | Details |
| A24547 | 22768812 | Rev Med Inst Mex Seguro Soc | Hepatic steatosis and type 2 diabetes mellitus in health workers. | 2012 | Details |
| A24548 | 22768070 | PLoS One | Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. | 2012 | Details |
| A24549 | 22764593 | Zhen Ci Yan Jiu | [Influence of electroacupuncture intervention on serum retinol binding protein 4 and liver function in nonalcoholic fatty liver rats]. | 2012 | Details |
| A24550 | 22764020 | Am J Gastroenterol | What should we recommend to our patients with NAFLD regarding alcohol use? | 2012 | Details |
| A24551 | 22760655 | Semin Liver Dis | Nonalcoholic fatty liver disease and HIV infection. | 2012 | Details |
| A24552 | 22760235 | JAMA | Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? | 2012 | Details |
| A24553 | 22753171 | Hepatology | Elovl6 promotes nonalcoholic steatohepatitis. | 2012 | Details |
| A24554 | 22753133 | Hepatology | Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. | 2012 | Details |
| A24555 | 22751848 | Int J Mol Med | Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis. | 2012 | Details |
| A24556 | 22751700 | Diabetes | Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. | 2012 | Details |
| A24557 | 22751691 | Diabetes | Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. | 2012 | Details |
| A24558 | 22751227 | Eur J Gastroenterol Hepatol | Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants. | 2012 | Details |
| A24559 | 22749559 | Drug Alcohol Depend | High-sensitivity γ-glutamyltransferase fraction pattern in alcohol addicts and abstainers. | 2012 | Details |
| A24560 | 22749338 | Ultrasound Med Biol | Transcutaneous vs. intraoperative quantitative ultrasound for staging bovine hepatic steatosis. | 2012 | Details |
| A24561 | 22749137 | J Nutr Biochem | Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. | 2012 | Details |
| A24562 | 22749135 | J Nutr Biochem | The role of dietary fatty acids in the pathology of metabolic syndrome. | 2012 | Details |
| A24563 | 22748277 | Atherosclerosis | Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. | 2012 | Details |